These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 31529159)
1. How adverse events and permanent medication stoppages affect changes in patients' beliefs about oral antineoplastic agents. Marshall VK; Given CW; Sikorskii A; Given BA; Lehto RH Support Care Cancer; 2020 Jun; 28(6):2589-2596. PubMed ID: 31529159 [TBL] [Abstract][Full Text] [Related]
2. Do treatment patterns alter beliefs cancer patients hold regarding oral oncolytic agents? Sikorskii A; Given CW; Given BA; Vachon E; Marshall V; Krauss JC; Banik A; Majumder A Psychooncology; 2018 Mar; 27(3):1005-1012. PubMed ID: 29232502 [TBL] [Abstract][Full Text] [Related]
3. The relationship between medication beliefs, patient activation, and self-rated health in patients taking oral anticancer agents. Hwang M; Cho Y; Gong Y; Jiang Y Support Care Cancer; 2024 Jun; 32(7):449. PubMed ID: 38904864 [TBL] [Abstract][Full Text] [Related]
4. Factors affecting medication beliefs among patients newly prescribed oral oncolytic agents. Marshall VK; Given CW; Given BA; Lehto RH; Sikorskii A J Psychosoc Oncol; 2022; 40(1):62-79. PubMed ID: 33305993 [TBL] [Abstract][Full Text] [Related]
5. The association between patients' perceived continuity of care and beliefs about oral anticancer treatment. Cohen Castel O; Shadmi E; Keinan-Boker L; Granot T; Karkabi K; Dagan E Support Care Cancer; 2019 Sep; 27(9):3545-3553. PubMed ID: 30689046 [TBL] [Abstract][Full Text] [Related]
7. Factors Associated With Medication Beliefs in Patients With Cancer: An Integrative Review. Marshall VK; Given BA Oncol Nurs Forum; 2018 Jul; 45(4):508-526. PubMed ID: 29947359 [TBL] [Abstract][Full Text] [Related]
8. Photo elicitation, an approach to better understanding the patient experience with OAAs: pilot study and future implications. Manojlovich M; Blok A; Wright N; Azhari E; Farris KB; Friese CR; Mackler E; Titler M; Byrnes M Support Care Cancer; 2023 Oct; 31(12):652. PubMed ID: 37878093 [TBL] [Abstract][Full Text] [Related]
9. Satisfaction With an Interactive Voice Response System and Symptom Management Toolkit Intervention to Improve Adherence in Patients Prescribed an Oral Anticancer Agent. Marshall VK; Given BA Oncol Nurs Forum; 2020 Nov; 47(6):637-648. PubMed ID: 33063783 [TBL] [Abstract][Full Text] [Related]
10. Impact of initiating oral anticancer agents for leukemia on adherence to medications for multiple chronic conditions. Gatwood J; Dashputre A; Rajpurohit A; Gatwood K; Mackler E; Wallace L; Farris K; Rizvi-Toner A; Farley J J Oncol Pharm Pract; 2024 Mar; 30(2):342-353. PubMed ID: 37113049 [TBL] [Abstract][Full Text] [Related]
12. The role of the pharmacist in improving medication beliefs and adherence in cancer patients. Birand N; Boşnak AS; Diker Ö; Abdikarim A; Başgut B J Oncol Pharm Pract; 2019 Dec; 25(8):1916-1926. PubMed ID: 30786821 [TBL] [Abstract][Full Text] [Related]
13. Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. Horne R; Weinman J J Psychosom Res; 1999 Dec; 47(6):555-67. PubMed ID: 10661603 [TBL] [Abstract][Full Text] [Related]
14. Temporary Stoppages and Burden of Treatment in Patients With Cancer. Vachon E; Given B; Given C; Dunn S Oncol Nurs Forum; 2019 Sep; 46(5):E135-E144. PubMed ID: 31424460 [TBL] [Abstract][Full Text] [Related]
15. A Concept Analysis of Oral Anticancer Agent Self-management. Mason M; Harris MR; Greer JA; Jiang Y Cancer Nurs; 2022 Mar-Apr 01; 45(2):E374-E387. PubMed ID: 33654013 [TBL] [Abstract][Full Text] [Related]
16. Treatment Patterns, Health Care Resource Utilization, and Spending in Medicaid Beneficiaries Initiating Second-generation Long-acting Injectable Agents Versus Oral Atypical Antipsychotics. Pilon D; Tandon N; Lafeuille MH; Kamstra R; Emond B; Lefebvre P; Joshi K Clin Ther; 2017 Oct; 39(10):1972-1985.e2. PubMed ID: 28919292 [TBL] [Abstract][Full Text] [Related]
17. Novel mobile application for direct communication between pharmacists and patients treated with oral antineoplastic agents. Collado-Borrell R; Escudero-Vilaplana V; Ribed A; Jiménez RR; Peinado II; Herranz-Alonso A; Sanjurjo-Sáez M Am J Health Syst Pharm; 2020 Aug; 77(17):1393-1402. PubMed ID: 32620958 [TBL] [Abstract][Full Text] [Related]
18. Adherence to oral antineoplastic agents in pediatric oncology. A multicenter study. Farberman D; Valente P; Malpiedi L; Morosi M; Luisella L; Arch Argent Pediatr; 2021 Feb; 119(1):44-50. PubMed ID: 33458980 [TBL] [Abstract][Full Text] [Related]
19. Outpatient oral anticancer agent utilization and costs in Manitoba from 2003 to 2016: a population-based study. Leong C; Czaykowski P; Geirnaert M; Katz A; Dragan R; Yogendran M; Raymond C Can J Public Health; 2021 Jun; 112(3):530-540. PubMed ID: 33471346 [TBL] [Abstract][Full Text] [Related]
20. A randomized controlled trial of the feasibility and preliminary efficacy of a texting intervention on medication adherence in adults prescribed oral anti-cancer agents: study protocol. Spoelstra SL; Given CW; Sikorskii A; Coursaris CK; Majumder A; DeKoekkoek T; Schueller M; Given BA J Adv Nurs; 2015 Dec; 71(12):2965-76. PubMed ID: 26100719 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]